KING RICHARD 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 13, 2012
Insider Transaction Report
Form 4
KING RICHARD
DirectorPresident and CEO
Transactions
- Award
Common Stock (Right to Buy)
2012-02-13−262,214→ 262,214 totalExercise: $3.39From: 2013-02-13Exp: 2022-02-12→ Common Stock (262,214 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 13, 2012) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F3]The shares have double-trigger acceleration on a change of control.